Bermuda Slashes GLP-1 Diabetes Drug Costs with Generics

Bermuda’s Diabetes Association is rolling out generic semaglutide (a GLP-1 drug) via its community pharmacy, making treatments for diabetes and obesity cheaper and more accessible. Generics offer the same active ingredient and quality at significantly lower prices, potentially cutting monthly costs by more than half and easing financial pressure on patients, insurers, and the healthcare system. The move follows insurer partnerships and ongoing efforts to bend healthcare costs while expanding access.